Peixoto A J, Santos S F, Mendes R B, Crowley S T, Maldonado R, Orias M, Mansoor G A, White W B
Sections of General Internal Medicine and Nephrology, Yale University School of Medicine, West Haven, CT, USA.
Am J Kidney Dis. 2000 Nov;36(5):983-90. doi: 10.1053/ajkd.2000.19100.
Ambulatory blood pressure monitoring (ABPM) has been increasingly used in hemodialysis (HD) practice and research; however, no study has evaluated the reproducibility of ABPM in this population. To address this question, we performed 48-hour interdialytic ABPM on 21 HD patients (mean age, 53 +/- 16 years; 7 women) on two different occasions 68 +/- 34 days (range, 30 to 154 days) apart. To qualify for the protocol, patients had to be at the same dry weight and on the same vasoactive drug regimen at both monitoring periods. BP was analyzed according to three different methods: isolated pre-HD and post-HD values, average pre-HD and post-HD values for the five HD sessions surrounding each monitoring period, and 48-hour interdialytic ABPM. Reproducibility was determined by analysis of the SD of the differences (SDD) between the two monitoring periods and the coefficient of variation of each method of BP determination. Our results show better reproducibility of ABPM (SDD, 10.6/6.6 mm Hg; coefficient of variation, 7.5%/8.1%) compared with isolated pre-HD BP (SDD, 24.4/11.3 mm Hg; coefficient of variation, 16.7%/14.1%) or post-HD BP (SDD, 16.8/14.5 mm Hg; coefficient of variation, 11.7%/17.8%), and averaged pre-HD BP (SDD, 14.7/7.2 mm Hg; coefficient of variation, 10.1%/9.1%) or post-HD BP (SDD, 12.4/8.7 mm Hg; coefficient of variation, 8.9%/11.1%). The reproducibility of the decrease in BP during sleep was poor, with up to 43% of the subjects changing dipping category within or between interdialytic periods. We conclude that ABPM is the most accurate method to study BP in HD patients over time. However, variability is significant, and there is poor reproducibility of the nocturnal decline in BP.
动态血压监测(ABPM)已越来越多地应用于血液透析(HD)的临床实践和研究中;然而,尚无研究评估ABPM在该人群中的可重复性。为解决这一问题,我们对21例HD患者(平均年龄53±16岁;7例女性)进行了两次间隔68±34天(范围30至154天)的48小时透析间期ABPM。为符合方案要求,患者在两个监测期的干体重必须相同且血管活性药物治疗方案一致。血压根据三种不同方法进行分析:透析前和透析后单次测量值、每个监测期前后五个HD疗程的透析前和透析后平均测量值以及48小时透析间期ABPM。通过分析两个监测期之间差异的标准差(SDD)以及每种血压测定方法的变异系数来确定可重复性。我们的结果显示,与透析前单次血压测量(SDD,24.4/11.3 mmHg;变异系数,16.7%/14.1%)或透析后单次血压测量(SDD,16.8/14.5 mmHg;变异系数,11.7%/17.8%),以及透析前平均血压(SDD,14.7/7.2 mmHg;变异系数,10.1%/9.1%)或透析后平均血压(SDD,12.4/8.7 mmHg;变异系数,8.9%/11.1%)相比,ABPM具有更好的可重复性(SDD,10.6/6.6 mmHg;变异系数,7.5%/8.1%)。睡眠期间血压下降的可重复性较差,高达43%的受试者在透析间期内或透析间期之间改变了血压波动类型。我们得出结论,ABPM是长期研究HD患者血压的最准确方法。然而,变异性很大,夜间血压下降的可重复性较差。